Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Buy” from Analysts
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock in the […]
More Stories
StockNews.com Downgrades Brightcove (NASDAQ:BCOV) to Buy
StockNews.com cut shares of Brightcove (NASDAQ:BCOV – Free Report) from a strong-buy rating to a buy rating in a research...
StockNews.com Upgrades Team (NYSE:TISI) to “Strong-Buy”
StockNews.com upgraded shares of Team (NYSE:TISI – Free Report) from a buy rating to a strong-buy rating in a research...
Chicago Rivet & Machine (NYSEAMERICAN:CVR) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Chicago Rivet & Machine (NYSEAMERICAN:CVR – Free Report) in a report published on Wednesday...
Aeries Technology (AERT) & Its Competitors Head-To-Head Comparison
Profitability This table compares Aeries Technology and its peers’ net margins, return on equity and return on assets. Net Margins...
Insider Selling: Secure Energy Services Inc. (TSE:SES) Insider Sells 2,995 Shares of Stock
Secure Energy Services Inc. (TSE:SES – Get Free Report) insider David Bonderman sold 2,995 shares of the company’s stock in...
Tensions Rise Over ICC Arrest Warrants for Netanyahu, Gallant as US Allies Mull Response
By Tom Ozimek Controversy is intensifying and the stakes are rising over the International Criminal Court’s (ICC) recent decision to...